Literature DB >> 11169458

Clusterin regulates vascular smooth muscle cell nodule formation and migration.

A J Millis1, M Luciani, H M McCue, M E Rosenberg, C L Moulson.   

Abstract

Vascular smooth muscle cells (VSMC) are the principal cellular component of the blood vessel wall where they exist in a differentiated state to maintain vascular tone. However, VSMC are not terminally differentiated and can be induced to dediffentiate, proliferate, and migrate. In fact, smooth muscle cell migration from the vascular wall into the lumen of the vessel is a central feature of occlusive vascular pathologies including atherosclerosis and intimal hyperplasia. In vitro, in the presence of an extracellular matrix, cultured vascular smooth muscle cells can migrate and invade the underlying gelatinous matrix, form multicellular nodular aggregations, and secrete the glycoprotein clusterin. Nodular cultures appear to mimic some of the properties of differentiated VSMC, in vivo. Here, to test the hypothesis that clusterin functions to modulate the formation of VSMC nodules and to facilitate cell migration a clusterin negative VSMC clone, SM-CLU13AS (Moulson and Millis, 1999, J Cell Physiol 180:355), was transiently transfected with plasmid pRcCMVCLU that contains the full-length porcine clusterin cDNA sequence under control of the CMV promoter. The transiently transfected VSMC culture expressed and secreted clusterin and formed nodules. To determine if clusterin regulates VSMC migration we used modified Boyden chamber assays. Clusterin, at 10 microg/ml, clearly promotes VSMC migration. In addition, a 15 amino acid synthetic peptide, representing amino acids 118-132 [KQTCMKFYARVCRSG] of the mature clusterin polypeptide, inhibits VSMC attachment to gelatinous substrate. Finally, clusterin appears to have a role in regulating endogenous clusterin expression in the clusterin negative clone. These results clearly establish that clusterin has functional role in VSMC nodule formation and support the conclusion that clusterin is a critical component of smooth muscle cell phenotypic modulation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169458     DOI: 10.1002/1097-4652(200102)186:2<210::AID-JCP1019>3.0.CO;2-N

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

Review 2.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

3.  Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.

Authors:  Yi-Wen Chen; Rongye Shi; Nicholas Geraci; Sheela Shrestha; Heather Gordish-Dressman; Lauren M Pachman
Journal:  BMC Immunol       Date:  2008-07-31       Impact factor: 3.615

4.  Contribution of the Transcription Factors Sp1/Sp3 and AP-1 to Clusterin Gene Expression during Corneal Wound Healing of Tissue-Engineered Human Corneas.

Authors:  Christelle Gross; Gaëtan Le-Bel; Pascale Desjardins; Manel Benhassine; Lucie Germain; Sylvain L Guérin
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

5.  Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects.

Authors:  Graziella E Ronsein; Tomas Vaisar; W Sean Davidson; Karin E Bornfeldt; Jeffrey L Probstfield; Kevin D O'Brien; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-06-17       Impact factor: 10.514

6.  Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.

Authors:  Teresia Hallström; Melanie Uhde; Birendra Singh; Christine Skerka; Kristian Riesbeck; Peter F Zipfel
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

7.  Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis.

Authors:  Lizzy Peix; Iona C Evans; David R Pearce; Juliet K Simpson; Toby M Maher; Robin J McAnulty
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

8.  Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosa.

Authors:  Andrew Vargas; Hwa Sun Kim; Erika Baral; Wan-Qing Yu; Cheryl Mae Craft; Eun-Jin Lee
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

9.  Effects of Rosuvastatin on Apolipoprotein J in Balloon-Injured Carotid Artery in Rats.

Authors:  Ning Yang; Bo Dong; Jinyu Yang; Yang Li; Lu Kou; Yue Liu; Qin Qin
Journal:  Arq Bras Cardiol       Date:  2018-09-21       Impact factor: 2.000

10.  Rosuvastatin Decreases the Formation of Neointima by Increasing Apo J, Reducing Restenosis after Balloon Injury in Rats.

Authors:  Paulo Magno Martins Dourado
Journal:  Arq Bras Cardiol       Date:  2018-10       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.